Company Cash Funds: repligen.com (RGEN)

Corporate emblem and logo of Repligen (RGEN)

Repligen Corporation (RGEN) supplies protein purification technologies to pharma behemoths, utilizing a profitable consumables sales model. Current production efficiency has reached a plateau, necessitating strict control over R&D expenditures. The cash level indicator reflects the dynamics of cash reserves, and the current value of 0.87 captures the liquidity balance. Elite bioengineers, attracted by generous stock options and a robust scientific foundation, sustain the business stability.

RGEN - Repligen Inc. Company Cash Volume over the range 07/04/2022 - 11/21/2026

Analytical breakdowns and data insights for company Repligen Corp (RGEN)

- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:RGEN Repligen
Brand item of Repligen

For Repligen Corporation (RGEN), which is expanding its influence in bioprocessing through the acquisition of niche players, maintaining liquidity is critical for executing its M&A strategy without incurring external debt. The trend in current cash balances demonstrates the business's degree of financial autonomy, allowing investors to assess the balance between accumulating reserves and investing in growth to prevent the stagnation of the company's competitive advantages.

Who Repligen Corporation competes with

Company Cash Volume TEM|QGEN - Company Cash Reserve|ionispharma.com - Company Cash on Hand|RNA: Company Cash and Cash Equivalents|CRSP: Company Cash on Hand|GeneDx Corp (WGS) - Company Cash on Hand|RARE: Company Cash Volume|BEAM - Company Liquid Assets|SRPT (Sarepta Therapeutics) - Company Cash Volume|Company Cash on Hand Twist Bioscience Inc (TWST)|Company Cash Volume TXG|Company Liquid Assets Intellia|Stoke - Company Cash on Hand|BLFS: Company Cash and Cash Equivalents|Wave Life Sciences Corp - Company Cash Volume|Maze Therapeutics, Inc. (MAZE) - Company Cash on Hand|Sionna Therapeutics Inc (SION) - Company Cash Funds|Company Cash on Hand Prime Medicine Corp|Company Cash Funds tayshagtx.com|QURE - Company Cash Position|Company Cash on Hand MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Company Cash Position|Company Cash Volume SLDB (Solid Biosciences Inc.)|Company Cash Balance OCGN|PacBio Corp - Company Cash Volume|Benitec Biopharma Inc. (BNTC) - Company Cash on Hand|DSGN: Company Cash Volume|Company Cash and Cash Equivalents RCKT|Company Cash on Hand FDMT|Company Cash and Cash Equivalents LXEO (Lexeo Therapeutics)|Company Cash Volume KRRO|Editas Medicine, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Silence Therapeutics Inc. SLN|Company Cash Volume ProQR Therapeutics N.V. PRQR|CDXS: Company Cash on Hand|Company Cash Position Sangamo (SGMO)|NAUT (Nautilus Bio) - Company Cash on Hand|MGX - Company Liquid Assets|DTIL (Precision BioSciences Inc.) - Company Cash Volume|generationbio.com (GBIO) - Company Liquid Assets|Company Cash Funds Boundless Bio Inc (BOLD)|Company Cash Volume Exicure Inc. (XCUR)|Company Cash Funds imunon.com IMNN|Company Cash Volume Phio Pharmaceuticals PHIO|Mustang Bio Inc - Company Cash Volume|Company Cash Reserve transcodetherapeutics.com|BNGO: Company Cash Volume|Company Cash and Cash Equivalents APDN|BLUE (bluebirdbio.com) - Company Cash Volume|Company Cash Reserve ImmunoPrecise Antibodies IPA|Company Cash on Hand OMGA (omegatherapeutics.com)|Company Cash Volume Singular Genomics Systems, Inc. (OMIC)|Company Cash Volume RGLS (Regulus Therapeutics, Inc.)|Company Cash Volume Syros SYRS|Telesis Bio, Inc. - Company Cash Volume|TRACON Pharmaceuticals (TCON) - Company Cash on Hand|UBX: Company Cash Volume